Upon PD1′s interaction with its ligand, the programmed death ligand (PDL1) that is expressed on surfaces of cancer cells, PD1 mediates a negative regulatory role in the anti-tumor activity of T cells [39]. This evidence concerns the gene PDCD1 and cancer.